AdvantiGen Biosciences was founded in 2015 to develop state-of-the-art deep tissue imaging technology with applications in both research and human diagnostics.
AdvantiGen specializes in the tracking of proteins and cells in vitro and in vivo using the Infrared (IR) region of the spectrum. Our IR optical imaging products allow the visualization of biological events in real time and the non-invasive imaging of both in vivo and ex vivo animal models. AdvantiGen’s IR products have lower background which results in dramatic improvements in both research and diagnostic imaging. The primary goals of AdvantiGen are to produce products that enable drug discovery, that lead to the development of diagnostics and that support basic and clinical research.